Origo Biopharma raises 2,3M€ in Series Seed financing with the participation from Sabadell Asabys, XesGalicia and the founding shareholders

by Asabys Partners

Origo Bio​pharm​a has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell As​abys, XesGalicia and the founding shareholders. The financing, led ...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream